Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

NCT00126984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

508

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Conjugated meningococcal ACWY-TT (vaccine)
BIOLOGICAL: DTPa/Hib containing vaccine
BIOLOGICAL: Meningitec
BIOLOGICAL: Mencevax ACWY

Sponsor

GlaxoSmithKline